You are here: Home » Companies » News
Business Standard

Sun Pharmaceutical gets USFDA inspection report for Dadra facility

The Mumbai based pharma major however did not share the details of the EIR

Press Trust of India  |  New Delhi 

medicine, drug, antibiotic, doctor, pharmaceuticals

Industries today said it has received establishment inspection report (EIR) from the US health regulator for its

The company said it had earlier indicated in the regulatory filings to the bourses that it was in the process of responding to the Form-483 observation letter issued by the after the inspection of its


"We are now pleased to inform you that the above referred inspection is closed," said in a filing.

The company has received "a communication from the (USFDA) releasing a copy of the EIR in respect of the above inspection based upon responses to the said observation letter", it added.

The based pharma major however did not share the details of the EIR.

In April, it had received 11 observations from the after the inspection of its

As per USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspection findings.

The stock closed at Rs 525.80, down 0.28 per cent, on

First Published: Wed, October 11 2017. 19:57 IST
RECOMMENDED FOR YOU